176 related articles for article (PubMed ID: 35887446)
1. Species Identification and In Vitro Antifungal Susceptibility of
Monpierre L; Aït-Ammar N; Valsecchi I; Normand AC; Guitard J; Riat A; Huguenin A; Bonnal C; Sendid B; Hasseine L; Raberin H; Dehais M; Ranque S; Hennequin C; Piarroux R; Dannaoui E; Botterel F
J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887446
[No Abstract] [Full Text] [Related]
2. Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory.
Barker AP; Horan JL; Slechta ES; Alexander BD; Hanson KE
Med Mycol; 2014 Jul; 52(5):537-45. PubMed ID: 24687961
[TBL] [Abstract][Full Text] [Related]
3. Identification of Paecilomyces variotii in clinical samples and settings.
Houbraken J; Verweij PE; Rijs AJ; Borman AM; Samson RA
J Clin Microbiol; 2010 Aug; 48(8):2754-61. PubMed ID: 20519470
[TBL] [Abstract][Full Text] [Related]
4. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus.
Luangsa-Ard J; Houbraken J; van Doorn T; Hong SB; Borman AM; Hywel-Jones NL; Samson RA
FEMS Microbiol Lett; 2011 Aug; 321(2):141-9. PubMed ID: 21631575
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous infection caused by Purpureocillium lilacinum: Case reports and literature review of infections by Purpureocillium and Paecilomyces in Taiwan.
Lu KL; Wang YH; Ting SW; Sun PL
J Dermatol; 2023 Aug; 50(8):1088-1092. PubMed ID: 37082787
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibilities of Paecilomyces species.
Aguilar C; Pujol I; Sala J; Guarro J
Antimicrob Agents Chemother; 1998 Jul; 42(7):1601-4. PubMed ID: 9660991
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility testing and molecular classification of Paecilomyces spp.
Castelli MV; Alastruey-Izquierdo A; Cuesta I; Monzon A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
Antimicrob Agents Chemother; 2008 Aug; 52(8):2926-8. PubMed ID: 18519716
[TBL] [Abstract][Full Text] [Related]
8. Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.
Sprute R; Salmanton-García J; Sal E; Malaj X; Ráčil Z; Ruiz de Alegría Puig C; Falces-Romero I; Barać A; Desoubeaux G; Kindo AJ; Morris AJ; Pelletier R; Steinmann J; Thompson GR; Cornely OA; Seidel D; Stemler J;
J Antimicrob Chemother; 2021 May; 76(6):1593-1603. PubMed ID: 33599275
[TBL] [Abstract][Full Text] [Related]
9. An unusual case of hyalohyphomycosis due to
Raghavan R; Chithra G; Fernandez S; Shamana Suryanarayana B; Singh R
Curr Med Mycol; 2018 Jun; 4(2):36-39. PubMed ID: 30324156
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Bruker Biotyper for identification of Penicillium marneffei, Paecilomyces species, Fusarium solani, Rhizopus species, and Pseudallescheria boydii.
Chen YS; Liu YH; Teng SH; Liao CH; Hung CC; Sheng WH; Teng LJ; Hsueh PR
Front Microbiol; 2015; 6():679. PubMed ID: 26217315
[TBL] [Abstract][Full Text] [Related]
11. Species Identification and
Imbert S; Normand AC; Ranque S; Costa JM; Guitard J; Accoceberry I; Bonnal C; Fekkar A; Bourgeois N; Houzé S; Hennequin C; Piarroux R; Dannaoui E; Botterel F
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439956
[No Abstract] [Full Text] [Related]
12. Keratomycosis due to
Juyal D; Pal S; Sharma M; Negi V; Adekhandi S; Tyagi M
Indian J Pathol Microbiol; 2018; 61(4):607-609. PubMed ID: 30303164
[TBL] [Abstract][Full Text] [Related]
13. Purpureocillium lilacinum an emergent pathogen: antifungal susceptibility of environmental and clinical strains.
Corrêa-Moreira D; de Lima Neto RG; da Costa GL; de Moraes Borba C; Oliveira MME
Lett Appl Microbiol; 2022 Jul; 75(1):45-50. PubMed ID: 35342967
[TBL] [Abstract][Full Text] [Related]
14. Polyphasic analysis of Purpureocillium lilacinum isolates from different origins and proposal of the new species Purpureocillium lavendulum.
Perdomo H; Cano J; Gené J; García D; Hernández M; Guarro J
Mycologia; 2013; 105(1):151-61. PubMed ID: 22893638
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
[TBL] [Abstract][Full Text] [Related]
16. Identification and Antifungal Susceptibility Profiles of
Hou X; Xiao M; Chen SC; Wang H; Yu SY; Fan X; Kong F; Xu YC
Front Microbiol; 2017; 8():5. PubMed ID: 28154553
[No Abstract] [Full Text] [Related]
17. Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers.
Todokoro D; Yamada N; Fukuchi M; Kishi S
Int Ophthalmol; 2014 Oct; 34(5):1159-63. PubMed ID: 24974133
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
19. Identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Testing of Non-
Li Y; Wang H; Hou X; Huang JJ; Wang PC; Xu YC
Front Microbiol; 2020; 11():922. PubMed ID: 32582045
[TBL] [Abstract][Full Text] [Related]
20. Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.
Hou X; Xiao M; Chen SC; Wang H; Cheng JW; Chen XX; Xu ZP; Fan X; Kong F; Xu YC
J Clin Microbiol; 2016 Nov; 54(11):2676-2680. PubMed ID: 27535688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
